<DOC>
	<DOC>NCT00525941</DOC>
	<brief_summary>NBI-34060 is an investigational (research) medication being studied in people with insomnia. The current study is designed to evaluate how people, who experience a nighttime awakening with difficulty returning to sleep, feel during the next day after dosing with NBI-34060. The study will also examine the pattern and extent of nighttime awakenings as reported by the patients, as well as and the patient's sleep experience during treatment.</brief_summary>
	<brief_title>An Exploratory Study of NBI-34060 Capsules and Next Day Functioning</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Indiplon</mesh_term>
	<criteria>insomnia (DSMIV diagnosed; at least one month) Nocturnal awakenings Usual bedtimes between 9:00PM and Midnight. Bedtimes that do not vary by more than 2 hours on 5 or more nights per week. A usual time in bed of 7 to 9 hours. no serious concomitant illness no other condition that could interfere with sleep</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>